Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab

Marta Casal Moura,Alvise Berti,Karina A. Keogh,Gerald W. Volcheck,Ulrich Specks,Misbah Baqir

Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab

2020

Marta Casal Moura
Alvise Berti
Karina A. Keogh
Gerald W. Volcheck
Ulrich Specks
Misbah Baqir

Objectives Rituximab (RTX) treatment is used for antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis, but its benefits in eosinophilic granulomatosis with polyangiitis (EGPA) are unclear. Our aim was to characterize asthma control and glucocorticoid (GC) sparing after RTX treatment.

Keywords:

Physical therapy
Autoantibody
Rituximab
Medicine
Glucocorticoid
Vasculitis
Granulomatosis with polyangiitis
Anti-neutrophil cytoplasmic antibody
Immunology
Eosinophilic
Asthma
Interquartile range
Internal medicine
Eosinophil
Gastroenterology
Atopy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations